Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor-Positive Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 05, 2023
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 29, 2023
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
Journal: NPJ breast cancer
Published: August 08, 2018
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.
Journal: Journal of the National Cancer Institute
Published: June 26, 2018
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.
Journal: Pharmacogenetics and genomics
Published: May 17, 2018
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: May 16, 2018
Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion.
Journal: Breast cancer research : BCR
Published: April 19, 2017
NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: March 14, 2017
Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).
Journal: Chinese clinical oncology
Published: December 23, 2016
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.
Journal: JAMA oncology
Published: November 05, 2016
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
Journal: Journal of the National Cancer Institute
Published: May 23, 2016
Last Updated: 09/26/2026